WallStSmart

CoreWeave, Inc. Class A Common Stock (CRWV)vsSynopsys Inc (SNPS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Synopsys Inc generates 56% more annual revenue ($8.01B vs $5.13B). SNPS leads profitability with a 13.8% profit margin vs -22.7%. SNPS earns a higher WallStSmart Score of 51/100 (C-).

CRWV

Avoid

30

out of 100

Grade: F

Growth: 6.3Profit: 2.0Value: 5.0Quality: 2.5
Piotroski: 3/9Altman Z: -0.14

SNPS

Buy

51

out of 100

Grade: C-

Growth: 6.7Profit: 5.0Value: 2.0Quality: 5.5
Piotroski: 1/9Altman Z: 1.48
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CRWV.

SNPSSignificantly Overvalued (-858.5%)

Margin of Safety

-858.5%

Fair Value

$44.68

Current Price

$420.32

$375.64 premium

UndervaluedFair: $44.68Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CRWV1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
110.4%10/10

Revenue surging 110.4% year-over-year

SNPS3 strengths · Avg: 9.0/10
Revenue GrowthGrowth
65.5%10/10

Revenue surging 65.5% year-over-year

Market CapQuality
$82.24B9/10

Large-cap with strong market position

Price/BookValuation
2.6x8/10

Reasonable price relative to book value

Areas to Watch

CRWV4 concerns · Avg: 3.3/10
Price/BookValuation
12.3x4/10

Trading at 12.3x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-50.3%2/10

ROE of -50.3% — below average capital efficiency

SNPS4 concerns · Avg: 2.5/10
Return on EquityProfitability
5.5%3/10

ROE of 5.5% — below average capital efficiency

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

PEG RatioValuation
2.812/10

Expensive relative to growth rate

P/E RatioValuation
65.3x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : CRWV

The strongest argument for CRWV centers on Revenue Growth. Revenue growth of 110.4% demonstrates continued momentum.

Bull Case : SNPS

The strongest argument for SNPS centers on Revenue Growth, Market Cap, Price/Book. Revenue growth of 65.5% demonstrates continued momentum.

Bear Case : CRWV

The primary concerns for CRWV are Price/Book, EPS Growth, Piotroski F-Score. Debt-to-equity of 4.54 is elevated, increasing financial risk.

Bear Case : SNPS

The primary concerns for SNPS are Return on Equity, Piotroski F-Score, PEG Ratio. A P/E of 65.3x leaves little room for execution misses.

Key Dynamics to Monitor

CRWV profiles as a hypergrowth stock while SNPS is a growth play — different risk/reward profiles.

CRWV is growing revenue faster at 110.4% — sustainability is the question.

SNPS generates stronger free cash flow (822M), providing more financial flexibility.

Monitor SOFTWARE - INFRASTRUCTURE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

SNPS scores higher overall (51/100 vs 30/100) and 65.5% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CoreWeave, Inc. Class A Common Stock

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

CoreWeave, Inc. operates a cloud platform that provides scaling, support, and acceleration for GenAI. The company is headquartered in Livingston, New Jersey.

Visit Website →

Synopsys Inc

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

Synopsys is an American electronic design automation company that focuses on silicon design and verification, silicon intellectual property and software security and quality. Products include logic synthesis, behavioral synthesis, place and route, static timing analysis, formal verification, hardware description language (SystemC, SystemVerilog/Verilog, VHDL) simulators, and transistor-level circuit simulation.

Visit Website →

Want to dig deeper into these stocks?